Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 325 of 399 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/16/23
End: 10/16/29
Due: 10/16/30
Phase: N/A
Priority: Normal
Start: 10/01/09
End: 09/23/17
Due: 09/23/18
Phase: N/A
Priority: Normal
Start: 06/30/01
End: 10/31/04
Due: 10/31/05
Phase: N/A
Priority: Normal
Start: 03/31/10
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 11/07/24
End: 10/01/27
Due: 10/01/28
Phase: N/A
Priority: Normal
Start: 09/11/18
End: 11/06/24
Due: 11/06/25
Phase: N/A
Priority: Normal
Start: 03/31/00
End: 06/30/08
Due: 06/30/09
Phase: N/A
Priority: Normal
Start: 07/16/08
End: 07/26/17
Due: 07/26/18
Phase: N/A
Priority: Normal
Start: 05/31/12
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 03/07/18
End: 08/06/21
Due: 08/06/22
Phase: N/A
Priority: Normal
Start: 01/02/22
End: 11/28/23
Due: 11/28/24
Phase: N/A
Priority: Normal
Start: 10/25/18
End: 06/25/25
Due: 06/25/26
Phase: N/A
Priority: Normal
Start: 11/30/96
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/08/21
End: 04/01/27
Due: 04/01/28
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 09/30/10
Due: 09/30/11
Phase: N/A
Priority: Normal
Start: 08/29/13
End: 02/24/20
Due: 02/24/21
Phase: N/A
Priority: Normal
Start: 05/08/15
End: 05/18/21
Due: 05/18/22
Phase: N/A
Priority: Normal
Start: 08/31/09
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 11/30/02
End: 05/31/07
Due: 05/31/08
Phase: N/A
Priority: Normal
Start: 10/31/01
End: 01/31/03
Due: 01/31/04
Phase: N/A
Priority: Normal
Start: 08/31/02
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/15/25
End: 11/30/28
Due: 11/30/29
Phase: N/A
Priority: Normal
Start: 05/17/23
End: 07/17/25
Due: 07/17/26
Phase: N/A
Priority: Normal
Start: 07/30/25
End: 04/01/27
Due: 04/01/28
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
Phase: N/A
Priority: Normal
Start: 03/31/12
End: 07/31/16
Due: 07/31/17